GCTK (GlucoTrack, Inc. Common Stock) Stock Analysis - Analyst Ratings

GlucoTrack, Inc. Common Stock (GCTK) is a publicly traded Healthcare sector company. As of May 21, 2026, GCTK trades at $0.47 with a market cap of $1.77M and a P/E ratio of 0.01. GCTK moved -13.39% today. Year to date, GCTK is -87.99%; over the trailing twelve months it is -94.71%. Its 52-week range spans $0.44 to $2,970.00. Rallies surfaces GCTK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

What do analysts rate GCTK?

The average price target is $0.00.

GCTK Key Metrics

Key financial metrics for GCTK
MetricValue
Price$0.47
Market Cap$1.77M
P/E Ratio0.01
EPS$31.22
Dividend Yield0.00%
52-Week High$2,970.00
52-Week Low$0.44
Volume15.42K
Avg Volume0
Revenue (TTM)$0
Net Income$-19.39M
Gross Margin0.00%

GCTK Analyst Consensus

GCTK analyst coverage data. Average price target: $0.00.

Latest GCTK News

Recent GCTK Insider Trades

  • SYCOFF DREW bought 182.54K (~$230.00K) on Apr 22, 2024.

Common questions about GCTK

What do analysts rate GCTK?
The average price target is $0.00.
Does Rallies show GCTK price targets?
Yes. Rallies tracks GCTK analyst ratings, consensus rating, average price target, upgrades, downgrades, analyst firms, and recent price target changes when available.
Is GCTK research on Rallies investment advice?
No. Rallies provides research, data, and educational context for GCTK. It does not provide personalized investment advice.
GCTK

GCTK